SGLT1 inhibitor

0 marketed 1 in Phase 3 1 in Phase 2

This page covers all SGLT1 inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting SGLT1 (sodium-glucose cotransporter 1), SGLT1.

Targets

SGLT1 (sodium-glucose cotransporter 1) · SGLT1

Phase 3 pipeline (1)

GSK1838262 Extended Release Tablets · XenoPort, Inc. · Diabetes
GSK1838262 is a selective inhibitor of sodium-dependent glucose cotransporter 1 (SGLT1) that reduces intestinal glucose absorption.

Phase 2 pipeline (1)

ASN008 · Formation Bio, Inc. · Diabetes
ASN008 is a small molecule that targets the SGLT1 transporter.